Basics Aquestive Therapeutics, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $778.38M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.71% Avg Daily Range (30 D): $0.20 | 3.23% Avg Daily Range (90 D): $0.17 | 3.13% Institutional Daily Volume Avg Daily Volume: .8M Avg Daily Volume (30 D): 2.39M Avg Daily Volume (90 D): 2.57M Trade Size Avg Trade Size (Sh.): 172 Avg Trade Size (Sh.) (30 D): 122 Avg Trade Size (Sh.) (90 D): 146 Institutional Trades Total Inst.Trades: 207 Avg Inst. Trade: $1.66M Avg Inst. Trade (30 D): $1.31M Avg Inst. Trade (90 D): $1.25M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.72M Avg Closing Trade (30 D): $1.28M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 366.85K     News Nov 10, 2025 @ 6:00 PM Food Allergy Market Valued at USD 3 Billion across... Source: Delveinsight Oct 8, 2025 @ 11:00 AM Aquestive Therapeutics Broadens Patent Estate for ... Source: Aquestive Therapeutics Sep 4, 2025 @ 11:00 AM Aquestive Therapeutics Announces that FDA Will Not... Source: Aquestive Therapeutics Aug 14, 2025 @ 10:00 AM Aquestive Therapeutics Announces $75M Strategic Fu... Source: Aquestive Therapeutics Jul 22, 2025 @ 11:00 AM Aquestive Therapeutics Names Sherry Korczynski as ... Source: Aquestive Therapeutics Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.7 $-.14 $-.14 Diluted EPS $-.7 $-.14 $-.14 Revenue $ 43.4M $ 12.81M $ 10M Gross Profit $ 26.16M $ 8.3M $ 5.44M Net Income / Loss $ -68.98M $ -15.45M $ -13.55M Operating Income / Loss $ -55.79M $ -11.48M $ -11.37M Cost of Revenue $ 17.24M $ 4.51M $ 4.56M Net Cash Flow $ 51.17M $ 68.53M $ -8.12M PE Ratio